Bulent Dabanlıoglu

7PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Microbial geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Probiotics as an alternative to eliminate Pseudomonas aeruginosa biofilm.

|Jul 22, 2026
Evaluation of gossypetin's effects on gut microbiota profile and TLR4, Myd88, NFKB, and NLRP3 signaling pathways in rats.

|Jul 06, 2026
Alternative therapy against CTX-M broad spectrum β-lactamase resistance gene in Klebsiella pneumoniae infection: bee venom and bee venom-derived nanovesicle fraction.

|Jun 09, 2026
Oral microbiota member Neisseria elongata exosomes-Cassia fistula association targets PTEN/AKT/IL10/IL1β/BAX/BCL-2 signaling pathway in pancreatic cancer immunotherapy.

|Apr 30, 2026
Biotechnological application of Escherichia coli outer membrane vesicles for the delivery of Myristica fragrans phytochemicals in pancreatic cancer therapy.

|Feb 19, 2026
Determinate the effects of Arabic gum and Lactobacillus acidophilus on the gut microbiota ALPK1/NFKB/NLRP6 and NLRP2 signaling pathway and virulence gene profile in rats with Campylobacter jejuni exosome application.

Mahmut Ucar, Ozgur Celebi, Demet Celebi

Pageof 2

Frequent Collaborators

6 joint publications

Sumeyye Baser

6 joint publications

Demet Celebi

6 joint publications

Ozgur Celebi

4 joint publications

Ali Taghizadehghalehjoughi